Emerging evidence of myocardial injury in COVID-19 : A path through the smoke
© The author(s)..
Although Coronavirus Disease 2019 (COVID-19) presents primarily as a respiratory condition, a growing body of evidence shows it is a systemic disease. Recently, many authors have described myocardial damage in COVID-19, suggesting various pathophysiological mechanisms. In this issue, Cao et al. demonstrate the prognostic value of cardiac troponin I in patients with COVID-19, showing how even minor elevations in this molecule carry a great impact on patient mortality. In a situation such as the worldwide COVID-19 pandemic, where healthcare resources are placed under enormous stress, readily available tests such as this play an important role in helping clinicians identify patients at greater risk of developing severe forms of the disease, and should be included in the initial triage panel.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Theranostics - 10(2020), 21 vom: 17., Seite 9888-9889 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tersalvi, Gregorio [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 14.09.2020 Date Revised 12.11.2023 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.7150/thno.50788 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314370889 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314370889 | ||
003 | DE-627 | ||
005 | 20231225152601.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.7150/thno.50788 |2 doi | |
028 | 5 | 2 | |a pubmed24n1047.xml |
035 | |a (DE-627)NLM314370889 | ||
035 | |a (NLM)32863965 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tersalvi, Gregorio |e verfasserin |4 aut | |
245 | 1 | 0 | |a Emerging evidence of myocardial injury in COVID-19 |b A path through the smoke |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.09.2020 | ||
500 | |a Date Revised 12.11.2023 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The author(s). | ||
520 | |a Although Coronavirus Disease 2019 (COVID-19) presents primarily as a respiratory condition, a growing body of evidence shows it is a systemic disease. Recently, many authors have described myocardial damage in COVID-19, suggesting various pathophysiological mechanisms. In this issue, Cao et al. demonstrate the prognostic value of cardiac troponin I in patients with COVID-19, showing how even minor elevations in this molecule carry a great impact on patient mortality. In a situation such as the worldwide COVID-19 pandemic, where healthcare resources are placed under enormous stress, readily available tests such as this play an important role in helping clinicians identify patients at greater risk of developing severe forms of the disease, and should be included in the initial triage panel | ||
650 | 4 | |a Editorial | |
650 | 4 | |a Introductory Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Myocardial injury | |
650 | 4 | |a Prognosis | |
650 | 4 | |a Risk stratification | |
650 | 4 | |a Troponin | |
700 | 1 | |a Veronese, Giacomo |e verfasserin |4 aut | |
700 | 1 | |a Winterton, Dario |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Theranostics |d 2011 |g 10(2020), 21 vom: 17., Seite 9888-9889 |w (DE-627)NLM20717458X |x 1838-7640 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2020 |g number:21 |g day:17 |g pages:9888-9889 |
856 | 4 | 0 | |u http://dx.doi.org/10.7150/thno.50788 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 10 |j 2020 |e 21 |b 17 |h 9888-9889 |